Table 1

Pre–eight-week intervention period participant characteristics according to diet allocation

Low polyphenol
(n=47)
High polyphenol
(n=46)
Between-group comparison
p value
Age (years)*55.6 (6.8)54.0 (6.7)0.235
Male (%)†28 (59.6)22 (47.8)0.301
Body mass index (kg/m2)*29.8 (5.0)31.6 (6.5)0.148
Systolic blood pressure (mm Hg)*141.7 (9.3)140.6 (8.9)0.589
Diastolic blood pressure (mm Hg)*85.5 (6.9)84.5 (7.6)0.460
Current smoker (%)†4 (8.5)6 (13.0)0.523
Former smoker (%)†24 (51.1)18 (39.1)0.300
Antihypertensive therapy (%)†37 (78.7)36 (78.3)0.999
Lipid-lowering therapy (%)†21 (44.7)19 (41.3)0.835
Total cholesterol (mmol/L)*5.2 (1.2)5.8 (1.3)0.020
HDL (mmol/L)*1.4 (0.4)1.4 (0.4)0.568
LDL (mmol/L)*4.2 (1.3)4.7 (1.4)0.038
Triglycerides (mmol/L)‡1.6 (1.0, 2.3)1.6 (1.1, 2.1)0.796
Total cholesterol/HDL ratio*3.9 (1.3)4.2 (1.2)0.267
Max response ACh (infused:non-infused) (%)*§123.9 (99.6)109.1 (84.7)0.447
Max response SNP
(infused:non-infused) (%)*§
126.3 (120.4)107.7 (70.1)0.369
  • Bold figures signify significant p values.

  • *Normally distributed data summarised as mean (SD). Difference between groups assessed using independent samples t test.

  • †Categorical variables are summarised as n (%). Difference between groups assessed using χ2 test.

  • ‡Skewed data were logarithmically transformed and presented as geometric mean (IQR). Difference between groups assessed using independent samples t test.

  • §Based on 92 subjects due to missing data for one participant in low-polyphenol group.

  • ACh, acetylcholine; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SNP, sodium nitroprusside.